4MBS
Crystal Structure of the CCR5 Chemokine Receptor
Summary for 4MBS
Entry DOI | 10.2210/pdb4mbs/pdb |
Descriptor | Chimera protein of C-C chemokine receptor type 5 and Rubredoxin, 4,4-difluoro-N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl}-1-phenylpropyl]cyclohexanecarboxamide, ZINC ION, ... (5 entities in total) |
Functional Keywords | human ccr5 chemokine receptor, anti-hiv agent, novel protein engineering, gpcr network, membrane protein, psi-biology, structural genomics, seven transmembrane helices, g protein-coupled receptor, membrane, signaling protein |
Biological source | Homo sapiens More |
Cellular location | Cell membrane ; Multi-pass membrane protein : P51681 |
Total number of polymer chains | 2 |
Total formula weight | 99756.11 |
Authors | Tan, Q.,Zhu, Y.,Han, G.W.,Li, J.,Fenalti, G.,Liu, H.,Cherezov, V.,Stevens, R.C.,GPCR Network (GPCR),Zhao, Q.,Wu, B. (deposition date: 2013-08-19, release date: 2013-09-11, Last modification date: 2023-09-20) |
Primary citation | Tan, Q.,Zhu, Y.,Li, J.,Chen, Z.,Han, G.W.,Kufareva, I.,Li, T.,Ma, L.,Fenalti, G.,Li, J.,Zhang, W.,Xie, X.,Yang, H.,Jiang, H.,Cherezov, V.,Liu, H.,Stevens, R.C.,Zhao, Q.,Wu, B. Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science, 341:1387-1390, 2013 Cited by PubMed Abstract: The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry. Here we report the 2.7 angstrom-resolution crystal structure of human CCR5 bound to the marketed HIV drug maraviroc. The structure reveals a ligand-binding site that is distinct from the proposed major recognition sites for chemokines and the viral glycoprotein gp120, providing insights into the mechanism of allosteric inhibition of chemokine signaling and viral entry. A comparison between CCR5 and CXCR4 crystal structures, along with models of co-receptor-gp120-V3 complexes, suggests that different charge distributions and steric hindrances caused by residue substitutions may be major determinants of HIV-1 co-receptor selectivity. These high-resolution insights into CCR5 can enable structure-based drug discovery for the treatment of HIV-1 infection. PubMed: 24030490DOI: 10.1126/science.1241475 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.71 Å) |
Structure validation
Download full validation report